Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.0850 (-1.43%) ($14.0850 - $14.0850) on Fri. Aug. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.41% (three month average) | RSI | 85 | Latest Price | $14.0850(-1.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 7.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VUG(33%) XLK(33%) VT(32%) BLOK(31%) URA(30%) | Factors Impacting BCRX price | BCRX will decline at least -2.205% in a week (0% probabilities). VIXM(-17%) UUP(-14%) SMH(-9%) EDOC(-5%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.205% (StdDev 4.41%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.41(-2.26%) | 10 Day Moving Average | $14.44(-2.46%) | 20 Day Moving Average | $13.09(7.6%) | To recent high | -5% | To recent low | 64.9% | Market Cap | $2.485b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |